FDA warns against compound semaglutide for diabetes and weight loss

Ozempic compound

The FDA has issued a warning urging people to avoid using off-brand or compound formulations of the popular semaglutide drugs Ozempic, Wegovy and Rybelsus. Semaglutide drugs such as Ozempic, Wegovy and Rybelsus have become the subject of a global shortage, with demand for the trending drugs outstripping supply. As a result, some people have turned … Read more

FDA approves Olaparib Plus Abiraterone and Prednisone or Prednisolone for BRCA-mutated metastatic castration-resistant prostate cancer

Be allowed

By the staff of ASCO Post Posted: 2/6/2023 12:43:00 Last update: 6/2/2023 12:38:22 On May 31, the U.S. Food and Drug Administration (FDA) approved olaparib (Lynparza) in combination with abiraterone and prednisone (or prednisolone) for adult patients with suspected or deleterious disease BRCA extensionmutated metastatic castration-resistant prostate cancer, as determined by an accompanying FDA-approved diagnostic … Read more